Plasmid DNA Manufacturing Market Value Growing US$ 300 mn by 2020 to 2027
According to the Acumen Research and Consulting, the global Plasmid DNA Manufacturing market is expected to reach at US$ 300 million by 2026, along with the projected CAGR of 20% from 2020-2026.
The published report global Plasmid DNA Manufacturing market provides a holistic overview of the current market covering the current trends. The provided quantitative and qualitative data is based on the deeper analysis of the historical data and the current market situation that helps to provide an overview of the forecasted period.
Get Sample PDF @ https://www.acumenresearchandconsulting.com/request-sample/1583
The global Plasmid DNA Manufacturing market report provides deeper insights on the factors driving the global market along with the factors that are responsible to hamper the growth. In addition, the report provides the opportunities in the global Plasmid DNA Manufacturing market that would help the competitors to increase the profit share.
The global Plasmid DNA Manufacturing market report provides the quantitative information of the target segment that is covered in the report along with the regional data comparison.
The report provides an overview value chain analysis, Porters Five analysis, and cost structure analysis gives an idea of the industrial outlook. The global Plasmid DNA Manufacturing market report covers the data of the major geographical regions such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In addition, the report also covers the country cross section providing deeper insights of the particular region.
The published global Plasmid DNA Manufacturing market report provides information about the major players operating in the target market. The company profile section provides important information about the major players, along with the financial overview, product segment revenue, the geographical presence of the company. It also provides information related to business development activities by the players such as merger & acquisition, partnerships and agreements.
The global Plasmid DNA Manufacturing market report also covers the products information that is offered by the particular players along with the specification. In addition, the player positioning based on their business strengths and product offerings which provides the competitive outlook of the industry.
Market participants
Aldevron, Cobra Biologics Limited, Delphi Genetics, VGXI, Inc., PlasmidFactory GmbH & Co. KG, LakePharma, Inc., Akron Biotech, Waisman Biomanufacturing, Richter-Helm BioLogics, Eurogentec, Kaneka Corporation, Nature Technology Corporation, Cell and Gene Therapy Catapult and among others.
Market segmentation
Market By Application
- Gene Therapy
- Vaccinology
Market By Disease
- Infectious Disease
- Cancer
- Genetic Disorder
Market By End use
- Research Institute
- Biotech Companies
Market By Region
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Spain
- Italy
- Rest of EU
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Rest of LA
- Middle East & Africa
- Saudi
- UAE
- Rest of MEA
Table of content
Chapter 1. Industry Overview of Plasmid DNA Manufacturing
1.1 Definition and Scope
1.1.1 Definition of Plasmid DNA Manufacturing
1.1.2 Market Segmentation
1.2 Summary
1.2.1 Market Snapshot
1.3 Global Plasmid DNA Manufacturing Market By Application
1.3.1 Global Plasmid DNA Manufacturing Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.3.2 Gene Therapy
1.3.3 Vaccinology
1.4 Global Plasmid DNA Manufacturing Market By Disease
1.4.1 Global Plasmid DNA Manufacturing Market Revenue and Growth Rate Comparison By Disease (2015-2026)
1.4.2 Infectious Disease
1.4.3 Genetic Disorders
1.4.4 Cancer
1.5 Global Plasmid DNA Manufacturing Market By End Use
1.5.1 Global Plasmid DNA Manufacturing Market Revenue and Growth Rate Comparison By End Use (2015-2026)
1.5.2 Research Institutes
1.5.3 Biotech Companies
1.6 Global Plasmid DNA Manufacturing Market by Regions
1.6.1 Global Plasmid DNA Manufacturing Market Size and Growth Rate Comparison by Regions (2015-2026)
1.6.2 North America Plasmid DNA Manufacturing Market Revenue And Growth Rate (2015-2026)
1.6.3 Europe Plasmid DNA Manufacturing Market Revenue And Growth Rate (2015-2026)
1.6.4 Asia-Pacific Plasmid DNA Manufacturing Market Revenue And Growth Rate (2015-2026)
1.6.5 Latin America Plasmid DNA Manufacturing Market Revenue And Growth Rate (2015-2026)
1.6.6 Middle East & Africa Plasmid DNA Manufacturing Market Revenue And Growth Rate (2015-2026)
Chapter 2. Market Dynamics and Competition Analysis
2.1 Market Drivers
2.2 Restraints and Challenges
2.3 Growth Opportunities
2.4 Porter’s Five Forces Analysis
2.4.1 Low Bargaining Power of Suppliers
2.4.2 Medium Bargaining Power of Buyers
2.4.3 High Threat of Substitute
2.4.4 Low Threat of New Entrants
2.4.5 High Degree of Competition
2.5 Value Chain Analysis
2.6 Cost structure Analysis
2.6.1 Raw Material and Suppliers
2.6.2 Proportion of Manufacturing Cost Structure
2.6.2.1 Raw Material
2.6.2.2 Labor Cost
2.6.2.3 Manufacturing Expense
2.7 Regulatory Compliance
2.8 Competitive Landscape, 2018
2.8.1 Player Positioning Analysis
2.8.2 Key Strategies Adopted By Leading Players
Chapter 3. Manufacturing Plant Analysis
3.1 Revenue and Commercial Date of Global Plasmid DNA Manufacturing Major Manufacturers in 2018
3.2 Manufacturing Plants Distribution of Global Plasmid DNA Manufacturing Major Manufacturers in 2018
Chapter 4. Plasmid DNA Manufacturing Market By Application
4.1 Global Plasmid DNA Manufacturing Revenue by Application
4.2 Gene Therapy
4.2.1 Market Revenue and Growth Rate, 2015 – 2026 (US$ Million)
4.2.2 Market Revenue and Forecast, By Region, 2015 – 2026 (US$ Million)
4.3 Vaccinology
4.3.1 Market Revenue and Growth Rate, 2015 – 2026 (US$ Million)
4.3.2 Market Revenue and Forecast, By Region, 2015 – 2026 (US$ Million)
Chapter 5. Plasmid DNA Manufacturing Market By Disease
5.1 Global Plasmid DNA Manufacturing Revenue by Disease
5.2 Infectious Disease
5.2.1 Market Revenue and Growth Rate, 2015 – 2026 (US$Mn)
5.2.2 Market Revenue and Forecast, By Region, 2015 – 2026 (US$Mn)
5.3 Genetic Disorders
5.3.1 Market Revenue and Growth Rate, 2015 – 2026 (US$Mn)
5.3.2 Market Revenue and Forecast, By Region, 2015 – 2026 (US$Mn)
5.4 Cancer
5.4.1 Market Revenue and Growth Rate, 2015 – 2026 (US$Mn)
5.4.2 Market Revenue and Forecast, By Region, 2015 – 2026 (US$Mn)
Chapter 6. Plasmid DNA Manufacturing Market By End Use
6.1 Global Plasmid DNA Manufacturing Revenue by End Use
6.2 Research Institutes
6.2.1 Market Revenue and Growth Rate, 2015 – 2026 (US$Mn)
6.2.2 Market Revenue and Forecast, By Region, 2015 – 2026 (US$Mn)
6.3 Biotech Companies
6.3.1 Market Revenue and Growth Rate, 2015 – 2026 (US$Mn)
6.3.2 Market Revenue and Forecast, By Region, 2015 – 2026 (US$Mn)
Chapter 7. North America Plasmid DNA Manufacturing Market By Country
7.1 North America Plasmid DNA Manufacturing Market Revenue and Growth Rate, 2015 – 2026 (US$ Million)
7.2 North America Plasmid DNA Manufacturing Market Revenue Share, by Country, 2018 (%)
7.3 U.S.
7.3.1 U.S. Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 – 2026 (US$ Million)
7.3.2 U.S. Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 – 2026 (US$ Million)
7.3.3 U.S. Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 – 2026 (US$ Million)
7.4 Canada
7.4.1 Canada Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 – 2026 (US$ Million)
7.4.2 Canada Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 – 2026 (US$ Million)
7.4.3 Canada Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 – 2026 (US$ Million)
Chapter 8. Europe Plasmid DNA Manufacturing Market By Country (8)
8.1 Europe Plasmid DNA Manufacturing Market Revenue and Growth Rate, 2015 – 2026 (US$ Million)
8.2 Europe Plasmid DNA Manufacturing Market Revenue Share, By Country, 2018 (%)
8.3 UK
8.3.1 UK Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 – 2026 (US$ Million)
8.3.2 UK Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 – 2026 (US$ Million)
8.3.3 UK Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 – 2026 (US$ Million)
8.4 Germany
8.4.1 Germany Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 – 2026 (US$ Million)
8.4.2 Germany Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 – 2026 (US$ Million)
8.4.3 Germany Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 – 2026 (US$ Million)
8.5 France
8.5.1 France Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 – 2026 (US$ Million)
8.5.2 France Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 – 2026 (US$ Million)
8.5.3 France Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 – 2026 (US$ Million)
8.6 Spain
8.6.1 Spain Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 – 2026 (US$ Million)
8.6.2 Spain Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 – 2026 (US$ Million)
8.6.3 Spain Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 – 2026 (US$ Million)
8.7 Italy
8.7.1 Italy Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 – 2026 (US$ Million)
8.7.2 Italy Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 – 2026 (US$ Million)
8.7.3 Italy Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 – 2026 (US$ Million)
8.8 Rest of Europe
8.8.1 Rest of Europe Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 – 2026 (US$ Million)
8.8.2 Rest of Europe Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 – 2026 (US$ Million)
8.8.3 Rest of Europe Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 – 2026 (US$ Million)
Chapter 9. Asia-Pacific Plasmid DNA Manufacturing Market By Country
9.1 Asia-Pacific Plasmid DNA Manufacturing Market Revenue and Growth Rate, 2015 – 2026 (US$ Million)
9.2 Asia-Pacific Plasmid DNA Manufacturing Market Revenue Share Comparison, By Country, 2015 & 2026 (%)
9.3 China
9.3.1 China Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 – 2026 (US$ Million)
9.3.2 China Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 – 2026 (US$ Million)
9.3.3 China Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 – 2026 (US$ Million)
9.4 Japan
9.4.1 Japan Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 – 2026 (US$ Million)
9.4.2 Japan Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 – 2026 (US$ Million)
9.4.3 Japan Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 – 2026 (US$ Million)
9.5 India
9.5.1 India Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 – 2026 (US$ Million)
9.5.2 India Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 – 2026 (US$ Million)
9.5.3 India Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 – 2026 (US$ Million)
9.6 Australia
9.6.1 Australia Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 – 2026 (US$ Million)
9.6.2 Australia Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 – 2026 (US$ Million)
9.6.3 Australia Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 – 2026 (US$ Million)
9.7 South Korea
9.7.1 South Korea Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 – 2026 (US$ Million)
9.7.2 South Korea Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 – 2026 (US$ Million)
9.7.3 South Korea Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 – 2026 (US$ Million)
9.8 Rest of Asia-Pacific
9.8.1 Rest of Asia-Pacific Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 – 2026 (US$ Million)
9.8.2 Rest of Asia-Pacific Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 – 2026 (US$ Million)
9.8.3 Rest of Asia-Pacific Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 – 2026 (US$ Million)
Chapter 10. Latin America Plasmid DNA Manufacturing Market By Country
10.1 Latin America Plasmid DNA Manufacturing Market Revenue and Growth Rate, 2015 – 2026 (US$ Million)
10.2 Latin America Plasmid DNA Manufacturing Market Revenue Share, by Country, 2018 (%)
10.3 Brazil
10.3.1 Brazil Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 – 2026 (US$ Million)
10.3.2 Brazil Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 – 2026 (US$ Million)
10.3.3 Brazil Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 – 2026 (US$ Million)
10.4 Mexico
10.4.1 Mexico Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 – 2026 (US$ Million)
10.4.2 Mexico Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 – 2026 (US$ Million)
10.4.3 Mexico Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 – 2026 (US$ Million)
10.5 Rest of Latin America
10.5.1 Rest of Latin America Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 – 2026 (US$ Million)
10.5.2 Rest of Latin America Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 – 2026 (US$ Million)
10.5.3 Rest of Latin America Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 – 2026 (US$ Million)
Chapter 11. Middle East & Africa Plasmid DNA Manufacturing Market By Country
11.1 Middle East & Africa Plasmid DNA Manufacturing Market Revenue and Growth Rate, 2015 – 2026 (US$ Million)
11.2 Middle East & Africa Plasmid DNA Manufacturing Market Revenue Share Comparison, By Countries, 2018 (%)
11.3 Saudi Arabia
11.3.1 Saudi Arabia Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 – 2026 (US$ Million)
11.3.2 Saudi Arabia Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 – 2026 (US$ Million)
11.3.3 Saudi Arabia Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 – 2026 (US$ Million)
11.4 UAE
11.4.1 UAE Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 – 2026 (US$ Million)
11.4.2 UAE Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 – 2026 (US$ Million)
11.4.3 UAE Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 – 2026 (US$ Million)
11.5 Rest of Middle East & Africa
11.5.1 Rest of Middle East & Africa Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 – 2026 (US$ Million)
11.5.2 Rest of Middle East & Africa Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 – 2026 (US$ Million)
11.5.3 Rest of Middle East & Africa Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 – 2026 (US$ Million)
Chapter 12. Major Manufacturers Analysis of Plasmid DNA
12.1 Cobra Biologics Limited
12.1.1 Business Overview
12.1.2 Company Profile
12.1.3 Cobra Biologics Limited 2018 Financial Analysis
12.1.4 Cobra Biologics Limited 2018 Plasmid DNA Business Region Distribution Analysis
12.1.5 Product Segment
12.1.6 Marketing Strategy and Recent Development
12.2 Novasep Inc.
12.2.1 Business Overview
12.2.2 Company Profile
12.2.3 Novasep Inc. 2018 Financial Analysis
12.2.4 Novasep Inc. 2018 Plasmid DNA Business Region Distribution Analysis
12.2.5 Product Segment
12.2.6 Marketing Strategy and Recent Development
12.3 Spark Therapeutics, Inc.
12.3.1 Business Overview
12.3.2 Company Profile
12.3.3 Spark Therapeutics, Inc. 2018 Financial Analysis
12.3.4 Spark Therapeutics, Inc. 2018 Plasmid DNA Business Region Distribution Analysis
12.3.5 Product Segment
12.3.6 Marketing Strategy and Recent Development
12.4 FUJIFILM Diosynth Biotechnologies Inc.
12.4.1 Business Overview
12.4.2 Company Profile
12.4.3 FUJIFILM Diosynth Biotechnologies Inc. 2018 Financial Analysis
12.4.4 FUJIFILM Diosynth Biotechnologies Inc. 2018 Plasmid DNA Business Region Distribution Analysis
12.4.5 Product Segment
12.4.6 Marketing Strategy and Recent Development
12.5 Cell and Gene Therapy Catapult
12.5.1 Business Overview
12.5.2 Company Profile
12.5.3 Cell and Gene Therapy Catapult 2018 Plasmid DNA Sales, Ex-factory Price, Revenue, Gross Margin Analysis
12.5.4 Cell and Gene Therapy Catapult 2018 Plasmid DNA Business Region Distribution Analysis
12.5.5 Product Segment
12.5.6 Marketing Strategy and Recent Development
12.6 Kaneka Eurogentec S.A (KANEKA)
12.6.1 Business Overview
12.6.2 Company Profile
12.6.3 Kaneka Eurogentec S.A 2018 Plasmid DNA Sales, Ex-factory Price, Revenue, Gross Margin Analysis
12.6.4 Kaneka Eurogentec S.A 2018 Plasmid DNA Business Region Distribution Analysis
12.6.5 Product Segment
12.6.6 Marketing Strategy and Recent Development
12.7 UniQure N.V.
12.7.1 Business Overview
12.7.2 Company Profile
12.7.3 uniQure N.V. Financial Analysis, 2019
12.7.4 uniQure N.V Plasmid DNA Business Region Distribution Analysis, 2019
12.7.5 Product Segment
12.7.6 Marketing Strategy and Recent Development
12.8 Lonza
12.8.1 Business Overview
12.8.2 Company Profile
12.8.3 Lonza Financial Analysis, 2018
12.8.4 Lonza Plasmid DNA Business Region Distribution Analysis, 2018
12.8.5 Product Segment
12.8.6 Marketing Strategy and Recent Development
12.9 Merk KgaA
12.9.1 Business Overview
12.9.2 Company Profile
12.9.3 Merk KgaA Financial Analysis, 2018
12.9.4 Merk KgaA Plasmid DNA Business Region Distribution Analysis, 2018
12.9.5 Product Segment
12.9.6 Marketing Strategy and Recent Development
Chapter 13. Research Approach
13.1 Methodology
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
Buy this premium report @ https://www.acumenresearchandconsulting.com/buy-now/0/1583
Contact us:
Sheetal k
Email: [email protected]
Phone: +14079154157 | +14089009135